Navigation Links
Education program leads to lasting improvement of cancer knowledge in African-Americans
Date:10/29/2007

LOS ANGELES, Oct. 28 Disparities in access to health care and education hinder minorities and socioeconomically disadvantaged populations from receiving needed cancer services and often lead to delayed cancer diagnoses. To determine the lasting impact of cancer education geared toward African-Americans, researchers with the University of Pittsburgh Medical Center (UPMC), in partnership with The Centers for Healthy Hearts and Souls, a Pittsburgh-based community health promotion organization, designed an outreach program that consisted of three education sessions. Study participants showed high levels of interest in cancer-related issues and notable retention and improvement in their knowledge about cancer after four months, according to findings presented today at the 49th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Los Angeles.

A number of barriers, both real and perceived, deter minorities from receiving much needed cancer services, said Dwight Heron, M.D., study co-author and assistant professor of radiation oncology at the University of Pittsburgh School of Medicine. Improved knowledge about cancer prevention and treatment can help us better reach patients and communities with the greatest needs, and address and overcome cultural and socioeconomic factors that often limit access to cancer services. This study points to the crucial influence an education program can have on cancer knowledge and attitudes, and is an important first step in breaking down barriers related to cancer disparities, said Dr. Heron.

Study participants included 38 African-Americans of varying ages, including a group of 10 residents of a Pittsburgh-based senior citizens center. Study investigators presented three education sessions: a culturally-adapted version of Cancer 101, a program on clinical trials developed by the National Cancer Institute and a scenario-based discussion of cancer-related subjects using the Cancer Knowledge Assessment Tool (CKAT). The CKAT was given prior to the cancer sessions and again four months later.

Pre-test results indicated that both the younger and older participants understood the importance of early detection and treatment for cancer, yet both groups appeared to have difficulty with the concept of cancer cell growth and hereditary risk factors. Both younger and older participants understood the purpose of clinical trials and their potential benefit, but few understood the meaning of a phase 3 clinical trial, and younger participants had less knowledge of the clinical trials process. Both groups coped well with difficult situations related to cancer on the CKAT. While younger participants scored better on scenarios related to radiation therapy concerns, health insurance and worries about biopsies, older participants scored better on a scenario related to the contribution of smoking to cancer.

Post-test results four months later indicated improvement in 36 percent of answers on the CKAT. Overall, younger participants showed greater improvement in knowledge than the older participants.


'/>"/>

Contact: Clare Collins
CollCX@upmc.edu
412-647-3555
University of Pittsburgh Schools of the Health Sciences
Source:Eurekalert

Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Education Levels Found To Predict Stress
3. Education in women brings sounder sleep
4. Education And Income Level May Not Guarantee Health
5. John Hopkins CGHH program provides Global Health education
6. AIDS awareness education for school children’
7. British medical education suffers shortage of bodies
8. Disadvantaged Students May Not Go In For College Education
9. Sex Education, Need Of The Hour In Public Schools
10. Medical education to sky rocket: in terms of fees!
11. Stop HIV/AIDS in its Tracks with Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... The ... from the NCQA. The accreditation covers StayWell’s asthma, coronary artery disease, congestive heart ... granted to organizations that have excellent programs for the delivery and improvement of ...
(Date:3/23/2017)... ... March 23, 2017 , ... March 23, 2017 - ... to easily reprint customer invoices, bills, statements and other correspondence when they have ... needed to retrieve and print the documents and batch them for efficient handling. ...
(Date:3/23/2017)... OR (PRWEB) , ... March 23, 2017 , ... Sharon ... Water, Global Climate Change and Your Health on VoiceAmerica, recently talked on her program ... she also used the occasion to remind listeners of an important distinction. World Water ...
(Date:3/23/2017)... ... March 23, 2017 , ... Corra Group is ... competitive pricing. Verisys through its FACIS and other services maintains the ... actions. , “We are delighted to be able to offer these various products ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... New MEDDEV 2.7/1 Rev. 4 Guidance, **An FDAnews Webinar**, April 4, 2017 ... will the new EU MDR language change the way manufacturers approach CERs? ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... 23, 2017  Cornerstone Pharmaceuticals, Inc., a ... milestone today.  Following successful End-of-Phase I (EOP1) ... and Drug Administration (FDA), the Company has ... path forward to conduct pivotal trials of ... acute myeloid leukemia (AML) and pancreatic cancer. ...
(Date:3/23/2017)... March 23, 2017 Piramal ... Limited, anuncia el nombramiento de Stuart E. ... plataforma de servicios integrados completa para su base ... cargo clave en el crecimiento y ejecución de ... responsable de impulsar todas las actividades de desarrollo ...
(Date:3/23/2017)... Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK ) ... a Phase 1 study of MM-310 in solid tumors. ... novel taxane and targets the EphA2 receptor, a protein ... major tumor types, including prostate, ovarian, bladder, gastric, pancreatic ... study is an important step in evaluating MM-310,s safety ...
Breaking Medicine Technology: